This CTLA-4:CD86 interaction forms a direct immunosuppressive axis that contributes to immune evasion, which appears particularly prominent in R/R cHL, including tumors previously exposed to PD-1 inhibitors. Here, CD86 is linked to classic Hodgkin lymphoma.